참고문헌 (140)

1. Nanoscale Res Lett A Akbarzadeh 8 1 1 2013 10.1186/1556-276X-8-102 Akbarzadeh A, Rezaei-Sadabady R, Davaran S, Joo SW, Zarghami N, Hanifehpour Y, Samiei M, Kouhi M, Nejati-Koshki K (2013) Liposome: classification, preparation, and applications. Nanoscale Res Lett 8(1):1-9 

   상세보기

2. Adv Drug Deliv Rev TA Al-Hilal 65 6 845 2013 10.1016/j.addr.2012.11.002 Al-Hilal TA, Alam F, Byun Y (2013) Oral drug delivery systems using chemical conjugates or physical complexes. Adv Drug Deliv Rev 65(6):845-864 

   상세보기

3. Hum Vaccin Immunother M Allahyari 12 3 806 2016 10.1080/21645515.2015.1102804 Allahyari M, Mohit E (2016) Peptide/protein vaccine delivery system based on PLGA particles. Hum Vaccin Immunother 12(3):806-828 

   상세보기

4. J Controll Release S Bashyal 2021 10.1016/j.jconrel.2021.08.060 Bashyal S, Seo J-E, Choi YW, Lee S (2021) Bile acid transporter-mediated oral absorption of insulin via hydrophobic ion-pairing approach. J Controll Release. https://doi.org/10.1016/j.jconrel.2021.08.060 

   상세보기

5. Nanomed: Nanotechnol Biol Med A Beloqui 12 1 143 2016 10.1016/j.nano.2015.09.004 Beloqui A, Solinís MÁ, Rodríguez-Gascón A, Almeida AJ, Préat V (2016) Nanostructured lipid carriers: promising drug delivery systems for future clinics. Nanomed: Nanotechnol Biol Med 12(1):143-161 

   상세보기

6. J Control Release A Bernkop-Schnürch 271 55 2018 10.1016/j.jconrel.2017.12.027 Bernkop-Schnürch A, Jalil A (2018) Do drug release studies from SEDDS make any sense? J Control Release 271:55-59 

   상세보기

7. J Pharm Investig P Blasi 49 4 337 2019 10.1007/s40005-019-00453-z Blasi P (2019) Poly (lactic acid)/poly (lactic-co-glycolic acid)-based microparticles: an overview. J Pharm Investig 49(4):337-346 

   상세보기

8. J Control Release S Bonengel 273 21 2018 10.1016/j.jconrel.2018.01.012 Bonengel S, Jelkmann M, Abdulkarim M, Gumbleton M, Reinstadler V, Oberacher H, Prüfert F, Bernkop-Schnürch A (2018) Impact of different hydrophobic ion pairs of octreotide on its oral bioavailability in pigs. J Control Release 273:21-29 

   상세보기

9. Expert Opin Drug Deliv DJ Brayden 2021 10.1080/17425247.2021.1942838 Brayden DJ, Maher S (2021) Transient permeation enhancer®(TPE®) technology for oral delivery of octreotide: a technological evaluation. Expert Opin Drug Deliv. https://doi.org/10.1080/17425247.2021.1942838 

   상세보기

10. Adv Drug Deliv Rev DJ Brayden 157 2 2020 10.1016/j.addr.2020.05.007 Brayden DJ, Hill T, Fairlie D, Maher S, Mrsny R (2020) Systemic delivery of peptides by the oral route: formulation and medicinal chemistry approaches. Adv Drug Deliv Rev 157:2-36 

    상세보기

11. Nat Rev Mater TD Brown 5 127 2019 10.1038/s41578-019-0156-6 Brown TD, Whitehead KA, Mitragotri S (2019) Materials for oral delivery of proteins and peptides. Nat Rev Mater 5:127-148 

    상세보기

12. Ther Deliv BJ Bruno 4 11 1443 2013 10.4155/tde.13.104 Bruno BJ, Miller GD, Lim CS (2013) Basics and recent advances in peptide and protein drug delivery. Ther Deliv 4(11):1443-1467 

    상세보기

13. Pharmaceutics U Bulbake 9 2 12 2017 10.3390/pharmaceutics9020012 Bulbake U, Doppalapudi S, Kommineni N, Khan W (2017) Liposomal formulations in clinical use: an updated review. Pharmaceutics 9(2):12 

    상세보기

14. Adv Drug Deliv Rev PS Burton 7 3 365 1991 10.1016/0169-409X(91)90014-4 Burton PS, Conradi RA, Hilgers AR (1991) (B) Mechanisms of peptide and protein absorption:(2) Transcellular mechanism of peptide and protein absorption: passive aspects. Adv Drug Deliv Rev 7(3):365-385 

    상세보기

15. Eur J Pharm Sci P Calceti 22 4 315 2004 10.1016/j.ejps.2004.03.015 Calceti P, Salmaso S, Walker G, Bernkop-Schnürch A (2004) Development and in vivo evaluation of an oral insulin-PEG delivery system. Eur J Pharm Sci 22(4):315-323 

    상세보기

16. Eur J Pharm Sci M Celik-Tekeli 158 105644 2021 10.1016/j.ejps.2020.105644 Celik-Tekeli M, Celebi N, Tekeli MY, Aktas Y (2021) Evaluation of the hypoglycemic effect of exendin-4’s new oral self-nanoemulsifying system in rats. Eur J Pharm Sci 158:105644 

    상세보기

17. Int J Pharm J Chamieh 559 228 2019 10.1016/j.ijpharm.2019.01.039 Chamieh J, Tarrat AD, Doudou C, Jannin V, Demarne F, Cottet H (2019) Peptide release from SEDDS containing hydrophobic ion pair therapeutic peptides measured by Taylor dispersion analysis. Int J Pharm 559:228-234 

    상세보기

18. VP Chavda 653 2017 10.1016/B978-0-323-46144-3.00025-8 Nanostructures for cancer therapy Chavda VP, Shah D (2017) Self-emulsifying delivery systems: one step ahead in improving solubility of poorly soluble drugs. Nanostructures for cancer therapy. Elsevier, Amsterdam, pp 653-718 

    

19. Pharm Res S Choi 20 12 2008 2003 10.1023/B:PHAM.0000008050.99985.5c Choi S, Kim SW (2003) Controlled release of insulin from injectable biodegradable triblock copolymer depot in ZDF rats. Pharm Res 20(12):2008-2010 

    상세보기

20. Int J Pharm W-G Dai 336 1 58 2007 10.1016/j.ijpharm.2006.11.035 Dai W-G, Dong LC (2007) Characterization of physiochemical and biological properties of an insulin/lauryl sulfate complex formed by hydrophobic ion pairing. Int J Pharm 336(1):58-66 

    상세보기

21. Eur J Pharm Sci S Das 47 1 139 2012 10.1016/j.ejps.2012.05.010 Das S, Ng WK, Tan RB (2012) Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs? Eur J Pharm Sci 47(1):139-151 

    상세보기

22. Int J Pharm MP de la Cruz-Moreno 528 1-2 471 2017 10.1016/j.ijpharm.2017.05.072 de la Cruz-Moreno MP, Montejo C, Aguilar-Ros A, Dewe W, Beck B, Stappaerts J, Tack J, Augustijns P (2017) Exploring drug solubility in fasted human intestinal fluid aspirates: impact of inter-individual variability, sampling site and dilution. Int J Pharm 528(1-2):471-484 

    상세보기

23. Int J Pharm C Dumont 541 1-2 117 2018 10.1016/j.ijpharm.2018.02.038 Dumont C, Bourgeois S, Fessi H, Jannin V (2018) Lipid-based nanosuspensions for oral delivery of peptides, a critical review. Int J Pharm 541(1-2):117-135 

    상세보기

24. Int J Pharm C Dumont 565 409 2019 10.1016/j.ijpharm.2019.05.037 Dumont C, Bourgeois S, Fessi H, Dugas P-Y, Jannin V (2019) In-vitro evaluation of solid lipid nanoparticles: ability to encapsulate, release and ensure effective protection of peptides in the gastrointestinal tract. Int J Pharm 565:409-418 

    상세보기

25. Int J Pharm C Dumont 586 119581 2020 10.1016/j.ijpharm.2020.119581 Dumont C, Beloqui A, Miolane C, Bourgeois S, Préat V, Fessi H, Jannin V (2020) Solid lipid nanocarriers diffuse effectively through mucus and enter intestinal cells-but where is my peptide? Int J Pharm 586:119581 

    상세보기

26. AAPS PharmSciTech NE Eleraky 21 3 88 2020 10.1208/s12249-020-1618-2 Eleraky NE, Swarnakar NK, Mohamed DF, Attia MA, Pauletti GM (2020) Permeation-enhancing nanoparticle formulation to enable oral absorption of enoxaparin. AAPS PharmSciTech 21(3):88 

    상세보기

27. Evaluate (2020) Evaluate pharma world preview 2020, outlook to 2026. https://www.evaluate.com/thought-leadership/pharma/evaluatepharma-world-preview-2020-outlook-2026. Accessed 16 Mar 2021 

28. Dan Med Bull J Fallingborg 46 3 183 1999 Fallingborg J (1999) Intraluminal pH of the human gastrointestinal tract. Dan Med Bull 46(3):183 

    상세보기

29. Eur J Pharm Biopharm T Fan 88 2 518 2014 10.1016/j.ejpb.2014.06.011 Fan T, Chen C, Guo H, Xu J, Zhang J, Zhu X, Yang Y, Zhou Z, Li L, Huang Y (2014) Design and evaluation of solid lipid nanoparticles modified with peptide ligand for oral delivery of protein drugs. Eur J Pharm Biopharm 88(2):518-528 

    상세보기

30. Drug Discov Today K Fosgerau 20 1 122 2015 10.1016/j.drudis.2014.10.003 Fosgerau K, Hoffmann T (2015) Peptide therapeutics: current status and future directions. Drug Discov Today 20(1):122-128 

    상세보기

31. J Pharm Sci H Friedl 102 12 4406 2013 10.1002/jps.23757 Friedl H, Dünnhaupt S, Hintzen F, Waldner C, Parikh S, Pearson JP, Wilcox MD, Bernkop-Schnürch A (2013) Development and evaluation of a novel mucus diffusion test system approved by self-nanoemulsifying drug delivery systems. J Pharm Sci 102(12):4406-4413 

    상세보기

32. Int J Chem Eng M Gallarate 2011 10.1155/2011/132435 Gallarate M, Battaglia L, Peira E, Trotta M (2011) Peptide-loaded solid lipid nanoparticles prepared through coacervation technique. Int J Chem Eng. https://doi.org/10.1155/2011/132435 

    상세보기

33. Adv Drug Deliv Rev JM Gamboa 65 6 800 2013 10.1016/j.addr.2013.01.003 Gamboa JM, Leong KW (2013) In vitro and in vivo models for the study of oral delivery of nanoparticles. Adv Drug Deliv Rev 65(6):800-810 

    상세보기

34. J Control Release K Gradauer 172 3 872 2013 10.1016/j.jconrel.2013.10.011 Gradauer K, Barthelmes J, Vonach C, Almer G, Mangge H, Teubl B, Roblegg E, Dünnhaupt S, Fröhlich E, Bernkop-Schnürch A (2013) Liposomes coated with thiolated chitosan enhance oral peptide delivery to rats. J Control Release 172(3):872-878 

    상세보기

35. Toxicology RL Grant 76 2 153 1992 10.1016/0300-483X(92)90162-8 Grant RL, Yao C, Gabaldon D, Acosta D (1992) Evaluation of surfactant cytotoxicity potential by primary cultures of ocular tissues: I. Characterization of rabbit corneal epithelial cells and initial injury and delayed toxicity studies. Toxicology 76(2):153-176 

    상세보기

36. Nat Protoc NJ Greenfield 1 6 2876 2006 10.1038/nprot.2006.202 Greenfield NJ (2006) Using circular dichroism spectra to estimate protein secondary structure. Nat Protoc 1(6):2876-2890 

    상세보기

37. Int J Pharm J Griesser 520 1-2 267 2017 10.1016/j.ijpharm.2017.02.019 Griesser J, Hetényi G, Moser M, Demarne F, Jannin V, Bernkop-Schnürch A (2017) Hydrophobic ion pairing: key to highly payloaded self-emulsifying peptide drug delivery systems. Int J Pharm 520(1-2):267-274 

    상세보기

38. Int J Pharm J Griesser 538 1-2 159 2018 10.1016/j.ijpharm.2018.01.018 Griesser J, Hetényi G, Kadas H, Demarne F, Jannin V, Bernkop-Schnürch A (2018) Self-emulsifying peptide drug delivery systems: how to make them highly mucus permeating. Int J Pharm 538(1-2):159-166 

    상세보기

39. Protein Sci GR Grimsley 18 1 247 2009 Grimsley GR, Scholtz JM, Pace CN (2009) A summary of the measured pK values of the ionizable groups in folded proteins. Protein Sci 18(1):247-251 

    상세보기

40. J Control Release V Gupta 172 2 541 2013 10.1016/j.jconrel.2013.05.002 Gupta V, Hwang BH, Doshi N, Mitragotri S (2013) A permeation enhancer for increasing transport of therapeutic macromolecules across the intestine. J Control Release 172(2):541-549 

    상세보기

41. Expert Opin Drug Deliv H Harde 8 11 1407 2011 10.1517/17425247.2011.604311 Harde H, Das M, Jain S (2011) Solid lipid nanoparticles: an oral bioavailability enhancer vehicle. Expert Opin Drug Deliv 8(11):1407-1424 

    상세보기

42. Int J Pharm S Hauptstein 487 1-2 25 2015 10.1016/j.ijpharm.2015.03.064 Hauptstein S, Prüfert F, Bernkop-Schnürch A (2015) Self-nanoemulsifying drug delivery systems as novel approach for pDNA drug delivery. Int J Pharm 487(1-2):25-31 

    상세보기

43. Adv Drug Deliv Rev DJ Hauss 59 7 667 2007 10.1016/j.addr.2007.05.006 Hauss DJ (2007) Oral lipid-based formulations. Adv Drug Deliv Rev 59(7):667-676 

    상세보기

44. J Pharm Sci DJ Hauss 87 2 164 1998 10.1021/js970300n Hauss DJ, Fogal SE, Ficorilli JV, Price CA, Roy T, Jayaraj AA, Keirns JJ (1998) Lipid-based delivery systems for improving the bioavailability and lymphatic transport of a poorly water-soluble LTB4 inhibitor. J Pharm Sci 87(2):164-169 

    상세보기

45. J Pharm Sci J Heade 107 6 1648 2018 10.1016/j.xphs.2018.02.012 Heade J, Maher S, Bleiel SB, Brayden DJ (2018) Labrasol® and salts of medium-chain fatty acids can be combined in low concentrations to increase the permeability of a macromolecule marker across isolated rat intestinal mucosae. J Pharm Sci 107(6):1648-1655 

    상세보기

46. Biochim Biophys Acta (BBA)-Protein Struct P-O Hegg 579 1 73 1979 10.1016/0005-2795(79)90088-6 Hegg P-O (1979) Precipitation of egg white proteins below their isoelectric points by sodium dodecyl sulphate and temperature. Biochim Biophys Acta (BBA)-Protein Struct 579(1):73-87 

    상세보기

47. Int J Pharm G Hetényi 523 1 357 2017 10.1016/j.ijpharm.2017.03.027 Hetényi G, Griesser J, Moser M, Demarne F, Jannin V, Bernkop-Schnürch A (2017) Comparison of the protective effect of self-emulsifying peptide drug delivery systems towards intestinal proteases and glutathione. Int J Pharm 523(1):357-365 

    상세보기

48. Int J Pharm F Hintzen 472 1-2 20 2014 10.1016/j.ijpharm.2014.05.047 Hintzen F, Perera G, Hauptstein S, Müller C, Laffleur F, Bernkop-Schnürch A (2014) In vivo evaluation of an oral self-microemulsifying drug delivery system (SMEDDS) for leuprorelin. Int J Pharm 472(1-2):20-26 

    상세보기

49. Expert Opin Drug Deliv M Ijaz 13 7 923 2016 10.1517/17425247.2016.1167034 Ijaz M, Bonengel S, Zupančič O, Yaqoob M, Hartl M, Hussain S, Huck CW, Bernkop-Schnürch A (2016) Development of oral self nano-emulsifying delivery system (s) of lanreotide with improved stability against presystemic thiol-disulfide exchange reactions. Expert Opin Drug Deliv 13(7):923-929 

    상세보기

50. Int J Nanomed ML Immordino 1 3 297 2006 10.2217/17435889.1.3.297 Immordino ML, Dosio F, Cattel L (2006) Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential. Int J Nanomed 1(3):297 

    상세보기

51. Eur J Pharm Biopharm R Ismail 2020 10.1016/j.ejpb.2020.04.025 Ismail R, Phan TNQ, Laffleur F, Csoka I, Bernkop-Schnürch A (2020) Hydrophobic ion pairing of a GLP-1 analogue for incorporating into lipid nanocarriers designed for oral delivery. Eur J Pharm Biopharm. https://doi.org/10.1016/j.ejpb.2020.04.025 

    상세보기

52. Crit Rev Biochem Mol Biol M Jackson 30 2 95 1995 10.3109/10409239509085140 Jackson M, Mantsch HH (1995) The use and misuse of FTIR spectroscopy in the determination of protein structure. Crit Rev Biochem Mol Biol 30(2):95-120 

    상세보기

53. Eur J Pharm Biopharm T Karamanidou 97 223 2015 10.1016/j.ejpb.2015.04.013 Karamanidou T, Karidi K, Bourganis V, Kontonikola K, Kammona O, Kiparissides C (2015) Effective incorporation of insulin in mucus permeating self-nanoemulsifying drug delivery systems. Eur J Pharm Biopharm 97:223-229 

    상세보기

54. Nanomedicine T Karamanidou 11 22 3009 2016 10.2217/nnm-2016-0265 Karamanidou T, Bourganis V, Kammona O, Kiparissides C (2016) Lipid-based nanocarriers for the oral administration of biopharmaceutics. Nanomedicine 11(22):3009-3032 

    상세보기

55. Drug Dev Ind Pharm H-J Kim 26 5 523 2000 10.1081/DDC-100101263 Kim H-J, Yoon KA, Hahn M, Park E-S, Chi S-C (2000) Preparation and in vitro evaluation of self-microemulsifying drug delivery systems containing idebenone. Drug Dev Ind Pharm 26(5):523-529 

    상세보기

56. Drug Discov Today K Kohli 15 21-22 958 2010 10.1016/j.drudis.2010.08.007 Kohli K, Chopra S, Dhar D, Arora S, Khar RK (2010) Self-emulsifying drug delivery systems: an approach to enhance oral bioavailability. Drug Discov Today 15(21-22):958-965 

    상세보기

57. Acta Pharm Sin B S Kollipara 4 5 333 2014 10.1016/j.apsb.2014.09.001 Kollipara S, Gandhi RK (2014) Pharmacokinetic aspects and in vitro-in vivo correlation potential for lipid-based formulations. Acta Pharm Sin B 4(5):333-349 

    상세보기

58. ACS Nano DJ Kozuch 14 5 6097 2020 10.1021/acsnano.0c01835 Kozuch DJ, Ristroph K, Prud’homme RK, Debenedetti PG (2020) Insights into hydrophobic ion pairing from molecular simulation and experiment. ACS Nano 14(5):6097-6106 

    상세보기

59. J Pharm Sci M Kurpiers 2020 10.1016/j.xphs.2020.07.024 Kurpiers M, Wolf JD, Spleis H, Steinbring C, Jörgensen AM, Matuszczak B, Bernkop-Schnürch A (2020) Lysine-based biodegradable surfactants: increasing the lipophilicity of insulin by hydrophobic ion paring. J Pharm Sci. https://doi.org/10.1016/j.xphs.2020.07.024 

    상세보기

60. Eur J Pharm Sci HT Lam 162 105658 2021 10.1016/j.ejps.2020.105658 Lam HT, Le N-MN, Phan TNQ, Bernkop-Schnürch A (2021) Mucolytic self-emulsifying drug delivery systems (SEDDS) containing a hydrophobic ion-pair of proteinase. Eur J Pharm Sci 162:105658 

    상세보기

61. Bioorg Med Chem JL Lau 26 10 2700 2018 10.1016/j.bmc.2017.06.052 Lau JL, Dunn MK (2018) Therapeutic peptides: historical perspectives, current development trends, and future directions. Bioorg Med Chem 26(10):2700-2707 

    상세보기

62. Int J Pharm C Leichner 530 1-2 346 2017 10.1016/j.ijpharm.2017.08.059 Leichner C, Menzel C, Laffleur F, Bernkop-Schnürch A (2017) Development and in vitro characterization of a papain loaded mucolytic self-emulsifying drug delivery system (SEDDS). Int J Pharm 530(1-2):346-353 

    상세보기

63. Expert Opin Drug Deliv G Leonaviciute 12 11 1703 2015 10.1517/17425247.2015.1068287 Leonaviciute G, Bernkop-Schnürch A (2015) Self-emulsifying drug delivery systems in oral (poly) peptide drug delivery. Expert Opin Drug Deliv 12(11):1703-1716 

    상세보기

64. Int J Pharm G Leonaviciute 508 1-2 102 2016 10.1016/j.ijpharm.2016.04.044 Leonaviciute G, Zupančič O, Prüfert F, Rohrer J, Bernkop-Schnürch A (2016) Impact of lipases on the protective effect of SEDDS for incorporated peptide drugs towards intestinal peptidases. Int J Pharm 508(1-2):102-108 

    상세보기

65. Eur J Pharm Biopharm G Leonaviciute 112 51 2017 10.1016/j.ejpb.2016.11.019 Leonaviciute G, Adamovic NT, Lam HT, Rohrer J, Partenhauser A, Bernkop-Schnürch A (2017) Self-emulsifying drug delivery systems (SEDDS): proof-of-concept how to make them mucoadhesive. Eur J Pharm Biopharm 112:51-57 

    상세보기

66. Int J Nanomed X Li 6 3151 2011 Li X, Chen D, Le C, Zhu C, Gan Y, Hovgaard L, Yang M (2011) Novel mucus-penetrating liposomes as a potential oral drug delivery system: preparation, in vitro characterization, and enhanced cellular uptake. Int J Nanomed 6:3151 

    상세보기

67. Expert Opin Drug Deliv P Li 9 10 1289 2012 10.1517/17425247.2012.717068 Li P, Nielsen HM, Müllertz A (2012) Oral delivery of peptides and proteins using lipid-based drug delivery systems. Expert Opin Drug Deliv 9(10):1289-1304 

    상세보기

68. J Pharm Sci P Li 102 8 2689 2013 10.1002/jps.23640 Li P, Nielsen HM, Fano M, Müllertz A (2013) Preparation and characterization of insulin-surfactant complexes for loading into lipid-based drug delivery systems. J Pharm Sci 102(8):2689-2698 

    상세보기

69. Int J Pharm P Li 477 1-2 390 2014 10.1016/j.ijpharm.2014.10.039 Li P, Tan A, Prestidge CA, Nielsen HM, Müllertz A (2014) Self-nanoemulsifying drug delivery systems for oral insulin delivery: in vitro and in vivo evaluations of enteric coating and drug loading. Int J Pharm 477(1-2):390-398 

    상세보기

70. J Pharm Investig M Li 2021 10.1007/s40005-021-00537-9 Li M, Kaminskas LM, Marasini N (2021) Recent advances in nano/microparticle-based oral vaccines. J Pharm Investig. https://doi.org/10.1007/s40005-021-00537-9 

    상세보기

71. J Control Release E Lipka 39 2-3 121 1996 10.1016/0168-3659(95)00145-X Lipka E, Crison J, Amidon GL (1996) Transmembrane transport of peptide type compounds: prospects for oral delivery. J Control Release 39(2-3):121-129 

    상세보기

72. Int J Pharm J Liu 560 377 2019 10.1016/j.ijpharm.2019.02.014 Liu J, Werner U, Funke M, Besenius M, Saaby L, Fanø M, Mu H, Müllertz A (2019a) SEDDS for intestinal absorption of insulin: Application of Caco-2 and Caco-2/HT29 co-culture monolayers and intra-jejunal instillation in rats. Int J Pharm 560:377-384 

    상세보기

73. Eur J Pharm Biopharm J Liu 144 217 2019 10.1016/j.ejpb.2019.09.022 Liu J, Xu Y, Liu Z, Ren H, Meng Z, Liu K, Liu Z, Yong J, Wang Y, Li X (2019b) A modified hydrophobic ion-pairing complex strategy for long-term peptide delivery with high drug encapsulation and reduced burst release from PLGA microspheres. Eur J Pharm Biopharm 144:217-229 

    상세보기

74. Protein Sci RO Loo 3 11 1975 1994 10.1002/pro.5560031109 Loo RO, Dales N, Andrews P (1994) Surfactant effects on protein structure examined by electrospray ionization mass spectrometry. Protein Sci 3(11):1975-1983 

    상세보기

75. Mol Pharm HD Lu 15 1 216 2018 10.1021/acs.molpharmaceut.7b00824 Lu HD, Rummaneethorn P, Ristroph KD, Prud’homme RK (2018) Hydrophobic ion pairing of peptide antibiotics for processing into controlled release nanocarrier formulations. Mol Pharm 15(1):216-225 

    상세보기

76. Acta Pharmacol Sin E-L Ma 27 10 1382 2006 10.1111/j.1745-7254.2006.00424.x Ma E-L, Ma H, Liu Z, Zheng C-X, Duan M-X (2006) In vitro and in vivo evaluation of a novel oral insulin formulation. Acta Pharmacol Sin 27(10):1382-1388 

    상세보기

77. Expert Opin Drug Deliv S Maher 18 2 273 2021 10.1080/17425247.2021.1825375 Maher S, Geoghegan C, Brayden DJ (2021) Intestinal permeation enhancers to improve oral bioavailability of macromolecules: reasons for low efficacy in humans. Expert Opin Drug Deliv 18(2):273-300 

    상세보기

78. Expert Opin Drug Deliv A Mahmood 13 11 1503 2016 10.1080/17425247.2016.1213236 Mahmood A, Prüfert F, Efiana NA, Ashraf MI, Hermann M, Hussain S, Bernkop-Schnürch A (2016) Cell-penetrating self-nanoemulsifying drug delivery systems (SNEDDS) for oral gene delivery. Expert Opin Drug Deliv 13(11):1503-1512 

    상세보기

79. Adv Drug Deliv Rev A Mahmood 142 91 2018 10.1016/j.addr.2018.07.001 Mahmood A, Bernkop-Schnürch A (2018) SEDDS: a game changing approach for the oral administration of hydrophilic macromolecular drugs. Adv Drug Deliv Rev 142:91-101 

    상세보기

80. J Control Release F McCartney 310 115 2019 10.1016/j.jconrel.2019.08.008 McCartney F, Jannin V, Chevrier S, Boulghobra H, Hristov DR, Ritter N, Miolane C, Chavant Y, Demarne F, Brayden DJ (2019) Labrasol® is an efficacious intestinal permeation enhancer across rat intestine: ex vivo and in vivo rat studies. J Control Release 310:115-126 

    상세보기

81. Clin J Pain CM McMurtry 2015 10.1097/AJP.0000000000000272 McMurtry CM, Riddell RP, Taddio A, Racine N, Asmundson GJ, Noel M, Chambers CT, Shah V (2015) Far from" just a poke": common painful needle procedures and the development of needle fear. Clin J Pain. https://doi.org/10.1097/AJP.0000000000000272 

    상세보기

82. J Control Release C Menzel 277 165 2018 10.1016/j.jconrel.2018.03.018 Menzel C, Holzeisen T, Laffleur F, Zaichik S, Abdulkarim M, Gumbleton M, Bernkop-Schnürch A (2018) In vivo evaluation of an oral self-emulsifying drug delivery system (SEDDS) for exenatide. J Control Release 277:165-172 

    상세보기

83. Pharm Res JD Meyer 15 2 188 1998 10.1023/A:1011998014474 Meyer JD, Manning MC (1998) Hydrophobic ion pairing: altering the solubility properties of biomolecules. Pharm Res 15(2):188-193 

    상세보기

84. Pharm Res JD Meyer 11 10 1492 1994 10.1023/A:1018916627891 Meyer JD, Matsuura JE, Ruth JA, Shefter E, Patel ST, Bausch J, McGonigle E, Manning MC (1994) Selective precipitation of interleukin-4 using hydrophobic ion pairing: a method for improved analysis of proteins formulated with large excesses of human serum albumin. Pharm Res 11(10):1492-1495 

    상세보기

85. Biopolym: Orig Res Biomol JD Meyer 35 5 451 1995 10.1002/bip.360350504 Meyer JD, Matsuura JE, Kendrick BS, Evans ES, Evans GJ, Manning MC (1995) Solution behavior of α-chymotrypsin dissolved in nonpolar organic solvents via hydrophobic ion pairing. Biopolym: Orig Res Biomol 35(5):451-456 

    상세보기

86. Int J Pept Protein Res JD Meyer 47 3 177 1996 10.1111/j.1399-3011.1996.tb01342.x Meyer JD, Kendrick BS, Matsuura JE, Ruth JA, Bryan PN, Manning MC (1996) Generation of soluble and active subtilisin and α-chymotrypsin in organic solvents via hydrophobic ion pairing. Int J Pept Protein Res 47(3):177-181 

    상세보기

87. Nat Rev Drug Discov S Mitragotri 13 9 655 2014 10.1038/nrd4363 Mitragotri S, Burke PA, Langer R (2014) Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies. Nat Rev Drug Discov 13(9):655-672 

    상세보기

88. Int J Pharm VJ Mohanraj 392 1-2 285 2010 10.1016/j.ijpharm.2010.03.061 Mohanraj VJ, Barnes TJ, Prestidge CA (2010) Silica nanoparticle coated liposomes: a new type of hybrid nanocapsule for proteins. Int J Pharm 392(1-2):285-293 

    상세보기

89. Chem Pharm Bull I Moriguchi 40 1 127 1992 10.1248/cpb.40.127 Moriguchi I, Hirono S, Liu Q, Nakagome I, Matsushita Y (1992) Simple method of calculating octanol/water partition coefficient. Chem Pharm Bull 40(1):127-130 

    상세보기

90. Drug Discov Today M Morishita 11 19-20 905 2006 10.1016/j.drudis.2006.08.005 Morishita M, Peppas NA (2006) Is the oral route possible for peptide and protein drug delivery? Drug Discov Today 11(19-20):905-910 

    상세보기

91. Adv Drug Deliv Rev E Moroz 101 108 2016 10.1016/j.addr.2016.01.010 Moroz E, Matoori S, Leroux J-C (2016) Oral delivery of macromolecular drugs: where we are after almost 100 years of attempts. Adv Drug Deliv Rev 101:108-121 

    상세보기

92. Adv Drug Deliv Rev RH Müller 54 S131 2002 10.1016/S0169-409X(02)00118-7 Müller RH, Radtke M, Wissing SA (2002) Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Deliv Rev 54:S131-S155 

    상세보기

93. Int J Pharm I Nazir 561 197 2019 10.1016/j.ijpharm.2019.03.001 Nazir I, Asim MH, Dizdarević A, Bernkop-Schnürch A (2019) Self-emulsifying drug delivery systems: impact of stability of hydrophobic ion pairs on drug release. Int J Pharm 561:197-205 

    상세보기

94. J Colloid Interface Sci AR Neves 463 258 2016 10.1016/j.jcis.2015.10.057 Neves AR, Queiroz JF, Lima SAC, Figueiredo F, Fernandes R, Reis S (2016) Cellular uptake and transcytosis of lipid-based nanoparticles across the intestinal barrier: relevance for oral drug delivery. J Colloid Interface Sci 463:258-265 

    상세보기

95. Int J Pharm Biol Sci PM Nigade 2 2 42 2012 Nigade PM, Patil SL, Tiwari SS (2012) Self emulsifying drug delivery system (SEDDS): a review. Int J Pharm Biol Sci 2(2):42-52 

96. Pharmaceutics I Nikolakakis 9 4 50 2017 10.3390/pharmaceutics9040050 Nikolakakis I, Partheniadis I (2017) Self-emulsifying granules and pellets: composition and formation mechanisms for instant or controlled release. Pharmaceutics 9(4):50 

    상세보기

97. P Novák 51 2016 10.1016/B978-0-444-63688-1.00004-5 Proteomic profiling and analytical chemistry Novák P, Havlíček V (2016) Protein extraction and precipitation. Proteomic profiling and analytical chemistry. Elsevier, Amsterdam, pp 51-62 

    

98. Int J Pharm M-J Park 441 1-2 757 2013 10.1016/j.ijpharm.2012.10.018 Park M-J, Balakrishnan P, Yang S-G (2013) Polymeric nanocapsules with SEDDS oil-core for the controlled and enhanced oral absorption of cyclosporine. Int J Pharm 441(1-2):757-764 

    상세보기

99. J Microencapsul A Patel 31 6 542 2014 10.3109/02652048.2014.885606 Patel A, Gaudana R, Mitra AK (2014) A novel approach for antibody nanocarriers development through hydrophobic ion-pairing complexation. J Microencapsul 31(6):542-550 

    상세보기

100. J Drug Target TNQ Phan 27 9 1017 2019 10.1080/1061186X.2019.1584200 Phan TNQ, Le-Vinh B, Efiana NA, Bernkop-Schnürch A (2019a) Oral self-emulsifying delivery systems for systemic administration of therapeutic proteins: science fiction? J Drug Target 27(9):1017-1024 

     상세보기

101. J Control Release TNQ Phan 304 146 2019 10.1016/j.jconrel.2019.05.011 Phan TNQ, Shahzadi I, Bernkop-Schnürch A (2019b) Hydrophobic ion-pairs and lipid-based nanocarrier systems: the perfect match for delivery of BCS class 3 drugs. J Control Release 304:146-155 

     상세보기

102. ACS Biomater Sci Eng TNQ Phan 2020 10.1021/acsbiomaterials.0c00637 Phan TNQ, Ismail R, Le-Vinh B, Zaichik S, Laffleur F, Bernkop-Schnürch A (2020) The effect of counterions in hydrophobic ion pairs on oral bioavailability of exenatide. ACS Biomater Sci Eng. https://doi.org/10.1021/acsbiomaterials.0c00637 

     상세보기

103. Mol Pharm NM Pinkerton 10 1 319 2013 10.1021/mp300452g Pinkerton NM, Grandeury A, Fisch A, Brozio JR, Riebesehl BU, Prud’homme RK (2013) Formation of stable nanocarriers by in situ ion pairing during block-copolymer-directed rapid precipitation. Mol Pharm 10(1):319-328 

     상세보기

104. Drug Deliv Transl Res M Plaza-Oliver 2021 10.1007/s13346-021-00908-7 Plaza-Oliver M, Santander-Ortega MJ, Lozano MV (2021) Current approaches in lipid-based nanocarriers for oral drug delivery. Drug Deliv Transl Res. https://doi.org/10.1007/s13346-021-00908-7 

     상세보기

105. Adv Drug Deliv Rev CW Pouton 25 1 47 1997 10.1016/S0169-409X(96)00490-5 Pouton CW (1997) Formulation of self-emulsifying drug delivery systems. Adv Drug Deliv Rev 25(1):47-58 

     상세보기

106. Pharmaceutics J Qiao 10 3 147 2018 10.3390/pharmaceutics10030147 Qiao J, Ji D, Sun S, Zhang G, Liu X, Sun B, Guan Q (2018) Oral bioavailability and lymphatic transport of pueraria flavone-loaded self-emulsifying drug-delivery systems containing sodium taurocholate in rats. Pharmaceutics 10(3):147 

     상세보기

107. Formul Dev Int J Pharm SVR Rao 362 1-2 2 2008 Rao SVR, Shao J (2008) Self-nanoemulsifying drug delivery systems (SNEDDS) for oral delivery of protein drugs: I. Formul Dev Int J Pharm 362(1-2):2-9 

108. Nanoscale Adv KD Ristroph 1 11 4207 2019 10.1039/C9NA00308H Ristroph KD, Prud’homme RK (2019) Hydrophobic ion pairing: encapsulating small molecules, peptides, and proteins into nanocarriers. Nanoscale Adv 1(11):4207-4237 

     상세보기

109. Mol Pharm K Ristroph 18 4 1666 2021 10.1021/acs.molpharmaceut.0c01132 Ristroph K, Salim M, Clulow AJ, Boyd BJ, Prud’homme RK (2021) Chemistry and geometry of counterions used in hydrophobic ion pairing control internal liquid crystal phase behavior and thereby drug release. Mol Pharm 18(4):1666-1676 

     상세보기

110. J Pharm Sci W Rubas 85 2 165 1996 10.1021/js950267+ Rubas W, Cromwell M, Shahrokh Z, Villagran J, Nguyen T-N, Wellton M, Nguyen T-H, Mrsny R (1996) Flux measurements across Caco-2 monolayers may predict transport in human large intestinal tissue. J Pharm Sci 85(2):165-169 

     상세보기

111. Int J Biol Macromol D Sakloetsakun 61 363 2013 10.1016/j.ijbiomac.2013.08.002 Sakloetsakun D, Dünnhaupt S, Barthelmes J, Perera G, Bernkop-Schnürch A (2013) Combining two technologies: multifunctional polymers and self-nanoemulsifying drug delivery system (SNEDDS) for oral insulin administration. Int J Biol Macromol 61:363-372 

     상세보기

112. Eur J Pharm Sci N Samiei 51 218 2014 10.1016/j.ejps.2013.10.002 Samiei N, Shafaati A, Zarghi A, Moghimi H, Foroutan S (2014) Enhancement and in vitro evaluation of amifostine permeation through artificial membrane (PAMPA) via ion pairing approach and mechanistic selection of its optimal counter ion. Eur J Pharm Sci 51:218-223 

     상세보기

113. Int J Pharm N Samiei 527 1-2 184 2017 10.1016/j.ijpharm.2017.05.042 Samiei N, Foroutan SM, Razipour F, Zarghi A, Shafaati A (2017) An investigation into the ability of alendronate ion pairs to increase oral absorption. Int J Pharm 527(1-2):184-190 

     상세보기

114. Int J Nanomed B Sarmento 2 4 743 2007 Sarmento B, Martins S, Ferreira D, Souto EB (2007) Oral insulin delivery by means of solid lipid nanoparticles. Int J Nanomed 2(4):743 

     상세보기

115. Eur J Pharm Sci X Sha 24 5 477 2005 10.1016/j.ejps.2005.01.001 Sha X, Yan G, Wu Y, Li J, Fang X (2005) Effect of self-microemulsifying drug delivery systems containing Labrasol on tight junctions in Caco-2 cells. Eur J Pharm Sci 24(5):477-486 

     상세보기

116. J Colloid Interface Sci I Shahzadi 531 253 2018 10.1016/j.jcis.2018.07.057 Shahzadi I, Dizdarević A, Efiana NA, Matuszczak B, Bernkop-Schnürch A (2018) Trypsin decorated self-emulsifying drug delivery systems (SEDDS): key to enhanced mucus permeation. J Colloid Interface Sci 531:253-260 

     상세보기

117. J Colloid Interface Sci I Shahzadi 552 287 2019 10.1016/j.jcis.2019.05.057 Shahzadi I, Asim MH, Dizdarević A, Wolf JD, Kurpiers M, Matuszczak B, Bernkop-Schnürch A (2019) Arginine-based cationic surfactants: Biodegradable auxiliary agents for the formation of hydrophobic ion pairs with hydrophilic macromolecular drugs. J Colloid Interface Sci 552:287-294 

     상세보기

118. Eur J Pharm Biopharm I Shahzadi 151 1 2020 10.1016/j.ejpb.2020.03.016 Shahzadi I, Nazir I, Phan TNQ, Bernkop-Schnürch A (2020) About the impact of superassociation of hydrophobic ion pairs on membrane permeability. Eur J Pharm Biopharm 151:1-8 

     상세보기

119. Eur J Pharm Biopharm G Sharma 76 2 159 2010 10.1016/j.ejpb.2010.07.002 Sharma G, Wilson K, Van der Walle C, Sattar N, Petrie J, Kumar MR (2010) Microemulsions for oral delivery of insulin: design, development and evaluation in streptozotocin induced diabetic rats. Eur J Pharm Biopharm 76(2):159-169 

     상세보기

120. Nanoscale N Shrestha 10 2 603 2018 10.1039/C7NR07736J Shrestha N, Bouttefeux O, Vanvarenberg K, Lundquist P, Cunarro J, Tovar S, Khodus G, Andersson E, Keita ÅV, Dieguez CG (2018) The stimulation of GLP-1 secretion and delivery of GLP-1 agonists via nanostructured lipid carriers. Nanoscale 10(2):603-613 

     상세보기

121. J Pharm Investig T Sim 46 4 351 2016 10.1007/s40005-016-0255-y Sim T, Lim C, Hoang NH, Joo H, Lee JW, Kim D-W, Lee ES, Youn YS, Kim JO, Oh KT (2016) Nanomedicines for oral administration based on diverse nanoplatform. J Pharm Investig 46(4):351-362 

     상세보기

122. J Drug Deliv Sci Technol S Sun 18 4 239 2008 10.1016/S1773-2247(08)50047-5 Sun S, Cui F, Kawashima Y, Liang N, Zhang L, Shi K, Yu Y (2008) A novel insulin-sodium oleate complex for oral administration: preparation, characterization and in vivo evaluation. J Drug Deliv Sci Technol 18(4):239-243 

     상세보기

123. Int J Nanomed S Sun 6 3049 2011 Sun S, Liang N, Kawashima Y, Xia D, Cui F (2011) Hydrophobic ion pairing of an insulin-sodium deoxycholate complex for oral delivery of insulin. Int J Nanomed 6:3049 

     상세보기

124. Expert Opin Drug Deliv J Swaminathan 9 12 1489 2012 10.1517/17425247.2012.735658 Swaminathan J, Ehrhardt C (2012) Liposomal delivery of proteins and peptides. Expert Opin Drug Deliv 9(12):1489-1503 

     상세보기

125. C Tanford 69 1963 Advances in protein chemistry Tanford C (1963) The interpretation of hydrogen ion titration curves of proteins. Advances in protein chemistry, vol 17. Elsevier, Amsterdam, pp 69-165 

126. J Control Release E Toorisaka 107 1 91 2005 10.1016/j.jconrel.2005.05.022 Toorisaka E, Hashida M, Kamiya N, Ono H, Kokazu Y, Goto M (2005) An enteric-coated dry emulsion formulation for oral insulin delivery. J Control Release 107(1):91-96 

     상세보기

127. Macromolecules M Torres-Lugo 32 20 6646 1999 10.1021/ma990541c Torres-Lugo M, Peppas NA (1999) Molecular design and in vitro studies of novel pH-sensitive hydrogels for the oral delivery of calcitonin. Macromolecules 32(20):6646-6651 

     상세보기

128. Int J Pharm RD Vaishya 489 1-2 237 2015 10.1016/j.ijpharm.2015.04.075 Vaishya RD, Mandal A, Gokulgandhi M, Patel S, Mitra AK (2015) Reversible hydrophobic ion-paring complex strategy to minimize acylation of octreotide during long-term delivery from PLGA microparticles. Int J Pharm 489(1-2):237-245 

     상세보기

129. Pharm Res J Wang 19 5 609 2002 10.1023/A:1015397811161 Wang J, Wu D, Shen W-C (2002) Structure-activity relationship of reversibly lipidized peptides: studies of fatty acid-desmopressin conjugates. Pharm Res 19(5):609-614 

     상세보기

130. Eur J Pharm Biopharm R Wibel 2020 10.1016/j.ejpb.2020.04.004 Wibel R, Friedl JD, Zaichik S, Bernkop-Schnürch A (2020) Hydrophobic ion pairing (HIP) of (poly) peptide drugs: benefits and drawbacks of different preparation methods. Eur J Pharm Biopharm. https://doi.org/10.1016/j.ejpb.2020.04.004 

     상세보기

131. Food Res Int L Xie 102 195 2017 10.1016/j.foodres.2017.10.007 Xie L, Wehling RL, Ciftci O, Zhang Y (2017) Formation of complexes between tannic acid with bovine serum albumin, egg ovalbumin and bovine beta-lactoglobulin. Food Res Int 102:195-202 

     상세보기

132. Drug Dev Ind Pharm L Yang 35 8 959 2009 10.1080/03639040902718039 Yang L, Cui F, Shi K, Cun D, Wang R (2009) Design of high payload PLGA nanoparticles containing melittin/sodium dodecyl sulfate complex by the hydrophobic ion-pairing technique. Drug Dev Ind Pharm 35(8):959-968 

     상세보기

133. J Pharm Sci HS Yoo 90 2 194 2001 10.1002/1520-6017(200102)90:2<194::AID-JPS10>3.0.CO;2-Q Yoo HS, Choi HK, Park TG (2001) Protein-fatty acid complex for enhanced loading and stability within biodegradable nanoparticles. J Pharm Sci 90(2):194-201 

     상세보기

134. Colloids Surf B H Yuan 70 2 248 2009 10.1016/j.colsurfb.2008.12.031 Yuan H, Jiang S-P, Du Y-Z, Miao J, Zhang X-G, Hu F-Q (2009) Strategic approaches for improving entrapment of hydrophilic peptide drugs by lipid nanoparticles. Colloids Surf B 70(2):248-253 

     상세보기

135. Int J Pharm N Zhang 327 1-2 153 2006 Zhang N, Ping Q, Huang G, Xu W, Cheng Y, Han X (2006) Lectin-modified solid lipid nanoparticles as carriers for oral administration of insulin. Int J Pharm 327(1-2):153-159 

136. J Control Release XH Zhou 29 3 239 1994 10.1016/0168-3659(94)90071-X Zhou XH (1994) Overcoming enzymatic and absorption barriers to non-parenterally administered protein and peptide drugs. J Control Release 29(3):239-252 

     상세보기

137. J Control Release O Zupančič 255 242 2017 10.1016/j.jconrel.2017.04.038 Zupančič O, Bernkop-Schnürch A (2017) Lipophilic peptide character-what oral barriers fear the most. J Control Release 255:242-257 

     상세보기

138. Eur J Pharm Biopharm O Zupančič 109 113 2016 10.1016/j.ejpb.2016.09.013 Zupančič O, Grieβinger JA, Rohrer J, de Sousa IP, Danninger L, Partenhauser A, Sündermann NE, Laffleur F, Bernkop-Schnürch A (2016a) Development, in vitro and in vivo evaluation of a self-emulsifying drug delivery system (SEDDS) for oral enoxaparin administration. Eur J Pharm Biopharm 109:113-121 

     상세보기

139. Drug Deliv O Zupančič 23 6 2074 2016 10.3109/10717544.2016.1143056 Zupančič O, Leonaviciute G, Lam HT, Partenhauser A, Podričnik S, Bernkop-Schnürch A (2016b) Development and in vitro evaluation of an oral SEDDS for desmopressin. Drug Deliv 23(6):2074-2083 

     

140. Drug Dev Ind Pharm O Zupančič 43 10 1694 2017 10.1080/03639045.2017.1338722 Zupančič O, Rohrer J, Thanh Lam H, Grießinger JA, Bernkop-Schnürch A (2017) Development and in vitro characterization of self-emulsifying drug delivery system (SEDDS) for oral opioid peptide delivery. Drug Dev Ind Pharm 43(10):1694-1702 

     상세보기